15
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Interoception Primes Emotional Processing: Multimodal Evidence from Neurodegeneration

      research-article
      1 , 2 , 3 , 1 , 2 , 3 , 2 , 4 , 5 , 1 , 1 , 2 , 1 , 2 , 3 , 2 , 6 , 2 , 6 , 1 , 2 , , 6 , 2 , 6 , 7 , 2 , 6 , 2 , 6 , 8 , 2 , 3 , 9 , 4 , 10 , 11 , 2 , 3 , 9 , 8 , 12 , 13 , 14 , 15 , 1 , 2 , 4 , 16 , 17 , , 1 , 2 , 4 , 7 ,
      The Journal of Neuroscience
      Society for Neuroscience
      Alzheimer's disease, behavioral variant frontotemporal dementia, emotion, interoception, Parkinson's disease, priming

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Recent frameworks in cognitive neuroscience and behavioral neurology underscore interoceptive priors as core modulators of negative emotions. However, the field lacks experimental designs manipulating the priming of emotions via interoception and exploring their multimodal signatures in neurodegenerative models. Here, we designed a novel task that involves interoceptive and control-exteroceptive priming conditions followed by post-interoception and post-exteroception facial emotion recognition (FER). We recruited 114 participants, including healthy controls (HCs) as well as patients with behavioral variant frontotemporal dementia (bvFTD), Parkinson's disease (PD), and Alzheimer's disease (AD). We measured online EEG modulations of the heart-evoked potential (HEP), and associations with both brain structural and resting-state functional connectivity patterns. Behaviorally, post-interoception negative FER was enhanced in HCs but selectively disrupted in bvFTD and PD, with AD presenting generalized disruptions across emotion types. Only bvFTD presented impaired interoceptive accuracy. Increased HEP modulations during post-interoception negative FER was observed in HCs and AD, but not in bvFTD or PD patients. Across all groups, post-interoception negative FER correlated with the volume of the insula and the ACC. Also, negative FER was associated with functional connectivity along the (a) salience network in the post-interoception condition, and along the (b) executive network in the post-exteroception condition. These patterns were selectively disrupted in bvFTD (a) and PD (b), respectively. Our approach underscores the multidimensional impact of interoception on emotion, while revealing a specific pathophysiological marker of bvFTD. These findings inform a promising theoretical and clinical agenda in the fields of nteroception, emotion, allostasis, and neurodegeneration.

          SIGNIFICANCE STATEMENT We examined whether and how emotions are primed by interoceptive states combining multimodal measures in healthy controls and neurodegenerative models. In controls, negative emotion recognition and ongoing HEP modulations were increased after interoception. These patterns were selectively disrupted in patients with atrophy across key interoceptive-emotional regions (e.g., the insula and the cingulate in frontotemporal dementia, frontostriatal networks in Parkinson's disease), whereas persons with Alzheimer's disease presented generalized emotional processing abnormalities with preserved interoceptive mechanisms. The integration of both domains was associated with the volume and connectivity (salience network) of canonical interoceptive-emotional hubs, critically involving the insula and the anterior cingulate. Our study reveals multimodal markers of interoceptive-emotional priming, laying the groundwork for new agendas in cognitive neuroscience and behavioral neurology.

          Related collections

          Most cited references171

          • Record: found
          • Abstract: found
          • Article: not found

          G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences

          G*Power (Erdfelder, Faul, & Buchner, 1996) was designed as a general stand-alone power analysis program for statistical tests commonly used in social and behavioral research. G*Power 3 is a major extension of, and improvement over, the previous versions. It runs on widely used computer platforms (i.e., Windows XP, Windows Vista, and Mac OS X 10.4) and covers many different statistical tests of the t, F, and chi2 test families. In addition, it includes power analyses for z tests and some exact tests. G*Power 3 provides improved effect size calculators and graphic options, supports both distribution-based and design-based input modes, and offers all types of power analyses in which users might be interested. Like its predecessors, G*Power 3 is free.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

            To develop a 10-minute cognitive screening tool (Montreal Cognitive Assessment, MoCA) to assist first-line physicians in detection of mild cognitive impairment (MCI), a clinical state that often progresses to dementia. Validation study. A community clinic and an academic center. Ninety-four patients meeting MCI clinical criteria supported by psychometric measures, 93 patients with mild Alzheimer's disease (AD) (Mini-Mental State Examination (MMSE) score > or =17), and 90 healthy elderly controls (NC). The MoCA and MMSE were administered to all participants, and sensitivity and specificity of both measures were assessed for detection of MCI and mild AD. Using a cutoff score 26, the MMSE had a sensitivity of 18% to detect MCI, whereas the MoCA detected 90% of MCI subjects. In the mild AD group, the MMSE had a sensitivity of 78%, whereas the MoCA detected 100%. Specificity was excellent for both MMSE and MoCA (100% and 87%, respectively). MCI as an entity is evolving and somewhat controversial. The MoCA is a brief cognitive screening tool with high sensitivity and specificity for detecting MCI as currently conceptualized in patients performing in the normal range on the MMSE.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              lmerTest Package: Tests in Linear Mixed Effects Models

                Bookmark

                Author and article information

                Journal
                J Neurosci
                J Neurosci
                jneuro
                jneurosci
                J. Neurosci
                The Journal of Neuroscience
                Society for Neuroscience
                0270-6474
                1529-2401
                12 May 2021
                12 May 2021
                : 41
                : 19
                : 4276-4292
                Affiliations
                [1] 1Cognitive Neuroscience Center, Universidad de San Andrés, Buenos Aires, Argentina
                [2] 2National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina
                [3] 3Facultad de Psicología, Universidad Nacional de Córdoba, Córdoba, Argentina
                [4] 4Global Brain Health Institute, University of California-San Francisco, San Francisco, California, and Trinity College Dublin, Dublin, Ireland
                [5] 5Nuclear Medicine School Foundation, National Commission of Atomic Energy, Mendoza, Argentina
                [6] 6Institute of Cognitive and Translational Neuroscience, INECO Foundation, Favaloro University, CONICET, Buenos Aires, Argentina
                [7] 7Latin American Brain Health (BrainLat), Universidad Adolfo Ibáñez, Santiago, Chile
                [8] 8Memory and Neuropsychiatric Clinic, Neurology Department, Hospital del Salvador, SSMO & Faculty of Medicine, University of Chile, Santiago, Chile
                [9] 9Instituto de Investigación Médica M. y M. Ferreyra, INIMEC-CONICET-UNC, Córdoba, Argentina
                [10] 10Department of Neurology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP Brazil
                [11] 11Department of Neurology, Hospital Santa Marcelina, Sao Paulo, SP Brazil
                [12] 12Gerosciences Center for Brain Health and Metabolism, Santiago, Chile
                [13] 13Neuropsychology and Clinical Neuroscience Laboratory, Physiopathology Department, ICBM, Neurosciences Department, Faculty of Medicine, University of Chile, Santiago, Chile
                [14] 14Servicio de Neurología, Departamento de Medicina, Clínica Alemana-Universidad del Desarrollo, Santiago, Chile
                [15] 15Neurología Cognitiva, Hospital Cesar Milstein, Buenos Aires, Argentina
                [16] 16Faculty of Education, National University of Cuyo, Mendoza, M5502JMA, Argentina
                [17] 17Departamento de Lingüística y Literatura, Facultad de Humanidades, Universidad de Santiago de Chile, Santiago, Chile
                Author notes
                Correspondence should be addressed to Agustín Ibáñez at agustin.ibanez@ 123456gbhi.org or Adolfo M. García at adolfomartingarcia@ 123456gmail.com

                Author contributions: A.I., P.C.S., A.L., L.S., A.Y., S.A., and A.M.G., designed research; P.C.S., A.L., S.F., A.B., A.G., S.A., A.N., M.M.C., F. Alifano, R.V., F. Anunziata, M.O.d.O., R.M.P., A.S., and C.S. performed research; P.C.S., A.L., L.S., S.M., M.F.-V., C.G.C., S.F., M.M., and A.B. analyzed data; P.C.S. and A.L. wrote the first draft of the paper; P.C.S., A.Y., R.M.P., A.M.G., and A.I. edited the paper; P.C.S., S.M., and A.I. wrote the paper.

                *P.C.S. and A.L. contributed equally to this work as first authors.

                Author information
                https://orcid.org/0000-0002-6936-0114
                Article
                JN-RM-2578-20
                10.1523/JNEUROSCI.2578-20.2021
                8143206
                33827935
                121627e7-ef1a-4db6-9369-1bd94fdc7111
                Copyright © 2021 Salamone, Legaz et al.

                This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

                History
                : 7 August 2020
                : 17 March 2021
                : 18 March 2021
                Funding
                Funded by: CONICET
                Funded by: ANID/FONDECYT
                Award ID: 1170010
                Funded by: FONDECYT-PICT
                Award ID: 2017-1818
                Funded by: ANID/FONDAP
                Award ID: 15150012
                Funded by: http://doi.org/10.13039/100007194Universidad de Santiago de Chile (Usach)
                Funded by: Global Brain Health Institute
                Award ID: GBHI ALZ UK-20-639295
                Funded by: RedLat
                Award ID: R01 AG057234
                Funded by: http://doi.org/10.13039/100000957Alzheimer's Association
                Award ID: SG-20-725707 GBHI ALZ / UK-20-639295
                Funded by: Tau Consortium
                Award ID: Tau Consortium
                Categories
                Research Articles
                Behavioral/Cognitive

                alzheimer's disease,behavioral variant frontotemporal dementia,emotion,interoception,parkinson's disease,priming

                Comments

                Comment on this article